1. Home
  2. PHGE vs CMLS Comparison

PHGE vs CMLS Comparison

Compare PHGE & CMLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • CMLS
  • Stock Information
  • Founded
  • PHGE 2015
  • CMLS 2002
  • Country
  • PHGE Israel
  • CMLS United States
  • Employees
  • PHGE N/A
  • CMLS N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • CMLS Broadcasting
  • Sector
  • PHGE Health Care
  • CMLS Consumer Discretionary
  • Exchange
  • PHGE Nasdaq
  • CMLS Nasdaq
  • Market Cap
  • PHGE 13.3M
  • CMLS 14.5M
  • IPO Year
  • PHGE N/A
  • CMLS 1998
  • Fundamental
  • Price
  • PHGE $0.60
  • CMLS $0.52
  • Analyst Decision
  • PHGE Strong Buy
  • CMLS Hold
  • Analyst Count
  • PHGE 2
  • CMLS 2
  • Target Price
  • PHGE $13.50
  • CMLS N/A
  • AVG Volume (30 Days)
  • PHGE 126.6K
  • CMLS 41.3K
  • Earning Date
  • PHGE 04-02-2025
  • CMLS 05-02-2025
  • Dividend Yield
  • PHGE N/A
  • CMLS N/A
  • EPS Growth
  • PHGE N/A
  • CMLS N/A
  • EPS
  • PHGE N/A
  • CMLS N/A
  • Revenue
  • PHGE N/A
  • CMLS $827,076,000.00
  • Revenue This Year
  • PHGE N/A
  • CMLS $0.63
  • Revenue Next Year
  • PHGE N/A
  • CMLS $5.25
  • P/E Ratio
  • PHGE N/A
  • CMLS N/A
  • Revenue Growth
  • PHGE N/A
  • CMLS N/A
  • 52 Week Low
  • PHGE $0.48
  • CMLS $0.50
  • 52 Week High
  • PHGE $6.30
  • CMLS $3.95
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 35.68
  • CMLS 26.89
  • Support Level
  • PHGE $0.60
  • CMLS $0.50
  • Resistance Level
  • PHGE $0.69
  • CMLS $0.64
  • Average True Range (ATR)
  • PHGE 0.11
  • CMLS 0.09
  • MACD
  • PHGE -0.04
  • CMLS -0.05
  • Stochastic Oscillator
  • PHGE 3.10
  • CMLS 4.20

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

About CMLS Cumulus Media Inc.

Cumulus Media Inc is an audio-first media company delivering content to over a quarter billion people every month wherever and whenever required. It is a radio broadcasting company combining high-quality local programming with iconic, nationally syndicated media, sports, and entertainment brands to deliver premium content choices to its customers and radio stations affiliated with Westwood One network and numerous digital channels. The company's revenue is derived mainly from the sale of local, regional, and national advertising which is broadcast on its radio stations.

Share on Social Networks: